1. Home
  2. MREO vs SLQT Comparison

MREO vs SLQT Comparison

Compare MREO & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • SLQT
  • Stock Information
  • Founded
  • MREO 2015
  • SLQT 1999
  • Country
  • MREO United Kingdom
  • SLQT United States
  • Employees
  • MREO N/A
  • SLQT N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • SLQT Specialty Insurers
  • Sector
  • MREO Health Care
  • SLQT Finance
  • Exchange
  • MREO Nasdaq
  • SLQT Nasdaq
  • Market Cap
  • MREO 438.8M
  • SLQT 386.9M
  • IPO Year
  • MREO N/A
  • SLQT 2020
  • Fundamental
  • Price
  • MREO $2.87
  • SLQT $2.40
  • Analyst Decision
  • MREO Strong Buy
  • SLQT Hold
  • Analyst Count
  • MREO 5
  • SLQT 2
  • Target Price
  • MREO $7.60
  • SLQT $3.38
  • AVG Volume (30 Days)
  • MREO 1.3M
  • SLQT 916.6K
  • Earning Date
  • MREO 08-12-2025
  • SLQT 05-12-2025
  • Dividend Yield
  • MREO N/A
  • SLQT N/A
  • EPS Growth
  • MREO N/A
  • SLQT N/A
  • EPS
  • MREO N/A
  • SLQT N/A
  • Revenue
  • MREO N/A
  • SLQT $1,488,701,000.00
  • Revenue This Year
  • MREO N/A
  • SLQT $17.72
  • Revenue Next Year
  • MREO $52.34
  • SLQT $13.05
  • P/E Ratio
  • MREO N/A
  • SLQT N/A
  • Revenue Growth
  • MREO N/A
  • SLQT 20.41
  • 52 Week Low
  • MREO $1.58
  • SLQT $1.62
  • 52 Week High
  • MREO $5.02
  • SLQT $6.86
  • Technical
  • Relative Strength Index (RSI)
  • MREO 61.43
  • SLQT 53.36
  • Support Level
  • MREO $2.63
  • SLQT $2.25
  • Resistance Level
  • MREO $2.85
  • SLQT $2.53
  • Average True Range (ATR)
  • MREO 0.16
  • SLQT 0.10
  • MACD
  • MREO -0.01
  • SLQT 0.04
  • Stochastic Oscillator
  • MREO 79.41
  • SLQT 65.79

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About SLQT SelectQuote Inc.

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

Share on Social Networks: